Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV) a randomised, double-blind, international phase 3 trial /

Weller Michael, Butowski Nicholas, Tran David D., Recht Lawrence D., Lim Michael, Hirte Hal, Ashby Lynn, Mechtler László, Goldlust Samuel A., Iwamoto Fabio, Drappatz Jan, O’Rourke Donald M., Wong Mark, Hamilton Mark G., Hideghéty Katalin
2017